Gewählte Publikation:
Stukova, MA; Sereinig, S; Zabolotnyh, NV; Ferko, B; Kittel, C; Romanova, J; Vinogradova, TI; Katinger, H; Kiselev, O; Egorov, A.
(2006):
Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein
TUBERCULOSIS. TUBERCULOSIS; 86: 236-246.
FullText
FullText_BOKU
- Abstract:
- We generated several attenuated recombinant influenza A vectors expressing the Mycobacterium tuberculosis early secretory antigenic target (ESAT-6) protein. The ESAT-6 protein was recently identified as one of the most promising protective antigens for cell-mediated immunity. The obtained vectors appeared to be capable of inducing ESAT-6 specific Th1 immune response in mice after intranasal immunization. We found that double immunization with two influenza vectors of different subtypes provided a significant level of protection in mice, when applied as prophylactic vaccine, as well as substantial therapeutic effect in mice with preestablished tuberculosis infection. Moreover, we found a strong synergistic effect when vaccination with Flu/ESAT-6 vectors was combined with isoniazid treatment, resulting in a dramatic reduction of bacterial. toad in the lungs of infected mice. (c) 2006 Elsevier Ltd. All rights reserved.
- Autor*innen der BOKU Wien:
-
Katinger Hermann
- Find related publications in this database (using NML MeSH Indexing)
-
Administration, Intranasal -
-
Animals -
-
Antigens, Bacterial - genetics
-
Antitubercular Agents - therapeutic use
-
Bacterial Proteins - genetics
-
Combined Modality Therapy -
-
Genetic Vectors - administration & dosage
-
Immunity, Cellular -
-
Immunization - methods
-
Influenza A virus - genetics
-
Isoniazid - therapeutic use
-
Mice -
-
Mice, Inbred C57BL -
-
Mycobacterium tuberculosis - immunology
-
Th1 Cells - immunology
-
Tuberculosis - immunology
-
Tuberculosis Vaccines - immunology
- Find related publications in this database (Keywords)
-
tuberculosis vaccine
-
influenza
-
ESAT-6
-
therapy
Altmetric: